J Korean Neurol Assoc.  1998 Aug;16(4):601-602.

A Case of Renal stones during treatment with Zonisamide

Affiliations
  • 1Department of Neurology, Catholic University Medical College, Seoul, Korea.

Abstract

Following its approval in Japan, zonisamide (Excegran ) has been accepted as a new antiepileptic drug having broad spectrum activity. However, it does not have marketing approval in the US. Clinical trials were suspended in the US because of the high incidence of renal stone development (3.7%). We experienced a case of renal calculus which was identified during the course of zonisamide treatment. We believe this is the first case report of renal stone development suspecting the causal relation to the zonisamide treatment in Korea.

Keyword

Zonisamide; renal calculi; epilepsy

MeSH Terms

Epilepsy
Incidence
Japan
Kidney Calculi
Korea
Marketing
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr